Corryn Biotechnologies is working to redefine the standard of complex wound care. Their novel “Advance Tissue Repair Platform” wound dressing technology will reduce the physical and psychological impact of wound care on both patients and carers – by fabricating advanced resorbable tissue scaffolds as wound dressings directly onto patients, without ever contacting the wound.

The safety and usability of Corryn’s ATR Platform has been demonstrated in preclinical studies. The company is currently seeking clinical wound care experts to support us as we move to clinical trial and market approval.